Centinel Spine® derived its name from the “Sentinel Sign” — the radiographic confirmation of a successful fusion anterior to the interbody device.
Above: A Radiograph Demonstrating the Sentinel Sign
As a company, Centinel Spine began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica, LLC and Surgicraft LTD.
Founded in 1990, Raymedica became the recognized leader in nucleus replacement devices through the development of revolutionary products like the PDN®
and HydraFlex®. Throughout its 18-year history, the company developed pioneering technologies and surgical approaches to the spine that helped thousands
of patients restore function, reduce back pain, and avoid more invasive procedures. Raymedica was also the first company to develop a system for the Antero-Lateral
Trans-Psoas Approach (ALPA)—implanting the PDN device via lateral access to the spine.
UK-based Surgicraft started spine-focused operations eight years earlier. In 1991, Surgicraft launched the revolutionary titanium Hartshill Horseshoe—the first stand-alone
anterior lumbar interbody fusion "STALIF®" device. Following 13 years of international clinical success, Surgicraft introduced the highly successful
STALIF TT® to the US spine market in 2004—thereby creating the No-Profile, Integrated Interbody Device market. With superior biomechanics
and design rationale, Surgicraft had an unparalleled clinical heritage in the Integrated Interbody space, spanning its entire 26-year history.
Today & Beyond
From the foundation of knowledge gained from the long-term clinical success of its lumbar products, Centinel launched its cervical product in 2008.
Today, Centinel Spine still embraces the pioneering culture developed at both Raymedica and Surgicraft, continuing on its corporate mission of:
Becoming the leading Anterior Column Support Spine franchise.
Providing elegantly simple implants and instruments that are tissue-sparing.
Generating superior clinical outcomes.
A.W. Showell (would become Surgicraft) LTD. is formed in Redditch, England to develop and manufacture fishing hooks and needles.
Responding to an evolving market, Surgicraft becomes more medically focused and begins the development of surgical instruments and devices.
Minneapolis-based Raymedica® is founded and embarks on an 18 year history of developing technologies that help spine patients reduce back pain and
avoid more complicated surgeries.
The Hartshill Horseshoe is launched by Surgicraft™, and becomes the first “stand-alone” integrated interbody device.
The STALIF® (STand Alone Lumbar Interbody Fusion implant) device is launched in Europe and the
Middle East, made from PEEK Optima® instead of titanium.
The STALIF TT™ lumbar device is developed by Surgicraft™ and introduced in the United States, creating the market for Integrated Interbody spacers.
FDA Approves prodisc L—the 2nd U.S. Lumbar Total Disc Replacement device.
FDA Approves prodisc C—the 1st Complete U.S. Cervical and Lumbar offering.
· Out of the merger-acquisition of Surgicraft™ and Raymedica®, Centinel Spine® is born with a continuing focus on
Integrated Interbody technology—addressing the importance for anterior column support.
· Centinel's history of long term clinical success in lumbar products creates the foundation for the introduction of the STALIF C®, an
Integrated Interbody device for cervical use.
The STALIF MIDLINE® Integrated Interbody lumbar spacer has a highly successful introduction, with more than 1,300 cages implanted in the first two years after launch.
The 25,000th STALIF device implanted marks a tangible validation of surgeon and patient support for Centinel Spine's Integrated Interbody technology.
The first cervical titanium surface PEEK device was implanted in the US: STALIF C-Ti™.
· The first cervical Integrated Interbody cleared for marketing by the FDA with multi-level and allogenic indications: STALIF C®
· The first posterior cervical screw designed and cleared for use by the FDA in the lateral masses: ALTOS® PCT
The 10,000th titanium surface STALIF® implanted — 3 years after launch.
Hear from a STALIF Patient:
Without a doubt I would recommend the surgery that I had because I have my life back.